Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5089771

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C1NC(N2CCNCC2)=N/C1=C\c1c[nH]c2ncccc12

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 2/20 0.42
▸ PIM2 Q9P1W9 2/20 0.42
▸ CHEK1 O14757 2/20 0.41
▸ PIM3 Q86V86 1/20 0.39
▸ KMT2A Q03164 1/20 0.38
▸ HASPIN Q8TF76 4/20 0.38
▸ CCNT1 O60563 2/20 0.38
▸ CDK9 P50750 2/20 0.38
▸ HRH4 Q9H3N8 2/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ CDC7 O00311 5/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.36
▸ CCND1 P24385 1/20 0.35
▸ CDK6 Q00534 1/20 0.35
▸ CHEK2 O96017 1/20 0.35
▸ CDK1 P06493 1/20 0.35
▸ SRC P12931 1/20 0.35
▸ CSNK2A2 P19784 1/20 0.35
▸ CSNK2B P67870 1/20 0.35
▸ CSNK2A1 P68400 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL4767358 0.87 CHEK1 (0.40) CHEK1KMT2AHASPINCCNT1CDK9
Hydrochloric Acid SCHEMBL5100845 0.87 PIM1 (0.44) PIM1PIM2CHEK1PIM3KMT2A
Hydrochloric Acid SCHEMBL5100863 0.87 PIM1 (0.44) PIM1PIM2CHEK1PIM3KMT2A
Trifluoroacetic Acid SCHEMBL5092686 0.86 CHEK1 (0.40) CHEK1KMT2AHASPINCCNT1CDK9
SCHEMBL5101244 0.84 CHEK1 (0.49) PIM1PIM2CHEK1PIM3KMT2A
SCHEMBL5101252 0.84 CHEK1 (0.49) PIM1PIM2CHEK1PIM3KMT2A
Trifluoroacetic Acid SCHEMBL5092991 0.83 PBK (0.44) CHEK1HASPINCCNT1CDK9JAK3
Hydrochloric Acid SCHEMBL4791429 0.83 CHEK1 (0.48) PIM1PIM2CHEK1PIM3KMT2A
Hydrochloric Acid SCHEMBL4791431 0.83 CHEK1 (0.48) PIM1PIM2CHEK1PIM3KMT2A
SCHEMBL5095241 0.82 CDC7 (0.47) PIM1PIM2CHEK1KMT2AHASPIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7371862-B2 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2008-05-13 — — US claimed
US-20070112020-A1 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2007-05-17 — — US claimed
US-7371862-B2 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PFIZER ITALIA S.R.L. (IT) 2008-05-13 — — US disclosed
US-20070112020-A1 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2007-05-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112020-A1 Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K20, MAP3K6, MAP3K1 PIM1 709/4885PIM2 762/4885CHEK1 251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback